Related Experiment Video
Updated: Jun 12, 2026

08:34
Robot-assisted Partial Splenectomy
Published on: January 2, 2026
Suture versus Sutureless Retroperitoneal Robot-assisted Partial Nephrectomy using Veriset™ Hemostatic Patch: A
Atanu Kumar Pal1, Jeni Mathew2, Rhea Ranjit Varma2
1Department of Urology, Vattikuti fellow of robotic Urologic Surgery, Aster Medcity, Kochi, Kerala.
Summary
Veriset™ hemostatic patch offers a sutureless alternative to renorrhaphy in robot-assisted partial nephrectomy, showing reduced console time, warm ischemia time, blood loss, and immediate GFR reduction.
Area of Science:
- Urology
- Surgical Innovation
- Minimally Invasive Surgery
Background:
- Robot-assisted partial nephrectomy (RAPN) is a standard procedure for kidney tumors.
- Conventional renorrhaphy can prolong operative time and contribute to complications.
- Exploring hemostatic agents as alternatives to sutures is crucial for improving surgical outcomes.
Purpose of the Study:
- To evaluate the efficacy of the Veriset™ hemostatic patch as a substitute for traditional renorrhaphy.
- To compare perioperative outcomes between Veriset™ and renorrhaphy in retroperitoneal RAPN.
Main Methods:
- A prospective study included 113 patients undergoing retroperitoneal RAPN.
- Propensity score matching was used to compare 32 patients receiving Veriset™ with 40 patients undergoing renorrhaphy.
- Key outcomes included operative time, ischemia time, blood loss, complications, and renal function.
Main Results:
- The Veriset™ group demonstrated significantly shorter console time and warm ischemia time (WIT).
- Blood loss and immediate postoperative GFR reduction were significantly lower in the Veriset™ group.
- Postoperative pain, transfusion rates, hospital stay, and readmissions were comparable between groups.
Conclusions:
- Veriset™ hemostatic patch is an effective sutureless alternative to renorrhaphy in retroperitoneal RAPN.
- This approach leads to improved perioperative efficiency and reduced immediate impact on renal function.
- Sutureless RAPN using Veriset™ offers favorable outcomes without increased complications.

